CD34 and graft versus host disease: IV injection of autologous CD34+ cells transduced with elivaldogene tavalentivec (Lenti-D) lentiviral vector to track MRI lesion magnitude, neurological function alterations, and graft-versus-host disease, death, and major functional impairments